An update on the human and animal enteric pathogen Clostridium perfringens.

Kiu R, Hall LJ. · 2018

Read An update on the human and animal enteric pathogen Clostridium perfringens. by Kiu R, Hall LJ. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6079034.txt.

Introduction

Kiu and Hall update knowledge of Clostridium perfringens, a toxin-heavy gut pathogen. Their review appeared in Emerging Microbes and Infections. The bacterium grows fast and makes over 20 toxins. It sickens both humans and farm animals. New genome tools made a fresh survey timely.

The review covers the bacterium's genes and virulence factors. It traces diseases from food poisoning to gas gangrene. Bowel disease in pre-term infants gets close attention. Typing and detection methods are summed up. Open questions close the survey. Readers get a current portrait of an old pathogen, pairing lab detail with clinical stakes.

Catalog record

CREATORKiu R, Hall LJ.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE78 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6079034

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

An update on the human and animal enteric pathogen Clostridium perfringens By Raymond Kiu, Lindsay J. Hall Published in: Emerging Microbes & Infections DOI: 10.1038/s41426-018-0144-8 ABSTRACT Clostridium perfringens, a rapid-growing pathogen known to secrete an arsenal of >20 virulent toxins, has been associated with intestinal diseases in both animals and humans throughout the past century. Recent advances in genomic analysis and experimental systems make it timely to re-visit this clinically and veterinary important pathogen. This Review will summarise our understanding of the genomics and virulence-linked factors, including antimicrobial potentials and secreted toxins of this gut pathogen, and then its up-to-date clinical epidemiology and biological role in the pathogenesis of several important human and animal-associated intestinal diseases, including pre-term necrotising enterocolitis. Finally, we highlight some of the important unresolved questions in relation to C. perfringens-mediated infections, and implications for future research directions. INTRODUCTION Clostridium perfringens (formerly known as Bacillus aerogenes capsulatus, Bacillus perfringens, Bacillus welchii or Clostridium welchii) is a Gram positive, spore-forming, anaerobic, rod-shaped bacterium1. It was first isolated and identified as a novel bacterium in 1891 by William H. Welch from the autopsy of a 38-year-old man, where gas bubbles were observed within infected blood vessels. This gas-forming trait (the original name Bacillus aerogenes capsulatus, ‘aerogenes’ literally means ‘air-producing’ in Latin) was later linked to gas gangrene symptoms seen in British and French soldiers during World War I2. C. perfringens is associated with diverse environments including soils, food, sewage, and as a member of the gastrointestinal (GI) tract microbial community (i.e., microbiota) of both diseased, and non-diseased humans and animals. Notably it has been associated with humans for thousands of years as evidenced by the recent identification of C. perfringens using next generation sequencing (NGS) technology in the mummified GI tract of a >5000-year-old Neolithic ‘Tyrolean Iceman’ (also known as Ötzi), found in an Alpine glacier in 19913. Clinically, C. perfringens has been constantly associated with various significant systemic and enteric diseases, in both humans and animals, including gas gangrene (Clostridial myonecrosis), food poisoning and non-foodborne diarrhoea, and enterocolitis4,5. Importantly, C. perfringens strains are known to secrete >20 identified toxins or enzymes that could potentially be the principal virulence factors involved in pathophysiology6. In this Review, we explore phenotypic and genomic features of this important and re-emerging pathogen, including virulence factors, and antimicrobial resistance (AMR) profiles, and the clinical impact of this bacterium in relation to numerous medically important intestinal diseases, across several host species. Finally, we highlight some of the important unresolved questions in relation to C. perfringens-associated infections, and implications for future research directions. ISOLATION, IDENTIFICATION AND TYPING METHODS There are numerous methods for isolation of C. perfringens, and biochemical and molecular methods for identification as detailed in Table 1.Table 1Common isolation, identification and typing methods used in C. perfringens researchMethodMethod details in briefRefsIsolation Direct platingDirect plating on TSC-EYA + 18–24 h anaerobic incubation at 37 °C. Pitch black colonies with opaque halos are presumptively C. perfringens. 146 Ethanol pre-treatmentEthanol pre-treatment (50% ethanol) for 30 mins + plating on Fastidious Anaerobe Agar (sometimes supplemented with 0.1% taurocholate). Colonies that exhibit beta-haemolysis are preliminarily identified as C. perfringens. 147 Biochemical identification Nagler’s reactionKnown as lecithinase (alpha-toxin) test. Egg-yolk agar plates are split into two halves, where one half contains anti-alpha-toxin, and following anaerobic incubation, positivity is defined as turbidity around colonies on the anti-alpha-toxin-free side which confirms C. perfringens. 148 Reverse CAMP testStreptococcus agalactiae is streaked on blood agar, and C. perfringens streaked perpendicular to S. agalactiae. After 24–48 h of anaerobic incubation, a ‘bow-tie’ zone will form due to the synergistic haemolysis, this confirms C. perfringens. 149 Molecular identification 16S ribosomal RNA PCRAppropriating full-length 16S rRNA universal primers/smaller region of 16S rRNA gene in PCR to amplify 16S rRNA gene + sequencing, and identify using informatics approach (based on sequence similarity >97% to assign taxonomy). 30 MALDI-TOF Mass SpectrometryRapid and inexpensive identification method based upon the mass spectrum analysis of highly-conserved ribosomal proteins from whole bacterial cells—apply bacterial colonies straight onto the MALDI-TOF metal target and followed by appropriate treatments and analysis. 4 Typing Multiplex PCRMultiplex PCR approach is commonly used to amplify key toxins genes to classify C. perfringens into 7 (A to G) different toxinotypes according to the toxin genes combination. 150 Genome-wide sequence searchGenome-wide search on relevant toxin genes using sequence similarity search program e.g. BLAST for toxinotyping on C. perfringens genomes. 10 As C. perfringens is a pathogen, typing methods are currently used to differentiate between strains that may be associated with serious infection (Table 1). C. perfringens strains, clinically well-known for toxin production, are typed (recently updated for seven toxinotypes: A–G; previously only types A–E7) according to the combination of typing toxins (Fig. 1) they produce, i.e., α-toxin, β-toxin, ε-toxin and ι-toxin, enterotoxin (CPE) and NetB8. Historically this method indicated that certain toxins were associated with certain hosts and diseases e.g., type B (particularly the β-toxin it harbours), is exclusively linked to dysentery in sheep, and rarely seen in other hosts9. Food-poisoning associated CPE was genotyped typically in type F strains (previously named as CPE-positive type A; not to be confused with heat-resistant type C strains) although CPE can also be produced by certain type C, D and E strains, whereas β2-toxin and θ-toxin (perfringolysin O; PFO) could be found in any toxinotypes1,10,11. However, it is important to note that no single strain is known to produce the entire panoply of toxins10.Fig. 1C. perfringens current toxinotyping system.The names of toxin genes are printed in grey GENOMIC INSIGHTS C. perfringens has a relatively low GC content, between 27–28%, and genome sizes range from 3.0–4.1 Mb, with 2500–3600 predicted genes present in each individual genome10. The first ever complete genome sequence of C. perfringens (strain 13) was published in early 2002; a historical gas gangrene-associated strain from 1939 (this also represents the first Gram-positive anaerobic pathogen to be sequenced)12. Virulence-linked genes within the sequence data include phospholipase C (α-toxin), hyaluronidase (µ-toxin), collagenase (κ-toxin), PFO (θ-toxin), and β2 toxin. Moreover, 61 sporulation-related and germination-related genes were encoded, which supports the fact that C. perfringens is a spore-former. Notably, most virulence genes in this type A strain were not found on genomic islands, or near insertion/transposase sequences, and GC content of those genes were similar to the average GC percentage, implying that horizontal gene transfer (HGT) of these toxin genes was an ancient evolutionary event. This study also highlighted differences in environmental adaption genes, including glycolytic enzymes, and sporulation-linked genes, whereas recent studies indicated that phylogenetic relationships between C. perfringens (based on core genome analysis) does not relate to clone origin or toxinotypes1,10 A recent large-scale genomic study that investigated 56 strains C. perfringens strains, representing the largest C. perfringens genomic study to date, revealed a diverse pangenome (a repertoire of genes in a defined number of genomes), with only 12.6% core genes (common genes that are present in each genome) (Fig. 2)10. A wide array of toxin genes was profiled in this study: α-toxin (plc), α-clostripain (ccp) and microbial collagenase (colA) were conserved in all examined genomes, the pore-forming toxin PFO gene pfo was found to be encoded in most genomes (>90%), whereas the food-poisoning causative toxin CPE gene cpe was consistently detected in historical

Read the complete text